Global Pharmaceutical Packaging Equipment Market - Global Forecast to 2027 - ResearchAndMarkets.com

2022-05-28 18:37:18 By : Ms. cnydlsz YDL-ESYS

DUBLIN, April 21, 2022--(BUSINESS WIRE)--The "Global Pharmaceutical Packaging Equipment Market by Product (Aseptic Packaging, Blister, Strip, Bottle, Tube, Carton, Case Packer, Wrapping Machine, Palletizing, Labeling & Serialization), Type (Tablet, Powder, Cream, Syrup, Aerosol) - Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical packaging equipment market is projected to reach USD 11.9 Billion by 2027 from USD 8.4 Billion in 2022, at a CAGR of 7.2% from 2022 to 2027.

The growth of the global pharmaceutical packaging equipment market is driven by the rapidly growing generic & biopharmaceutical markets, growth in OTC drug sales, rising need for flexible and integrated packaging equipment, increased offshore manufacturing in the pharmaceuticals market, the introduction of regulatory standards on the packaging, and stringent norms against counterfeiting.

However, factors such as the adoption of refurbished packaging equipment and the high cost of packaging equipment are expected to restrain market growth to a certain extent during the forecast period.

The primary packaging equipment segment is expected to account for the largest share of the pharmaceutical packaging equipment market

The primary packaging equipment segment accounted for the largest share of the pharmaceutical packaging equipment market. The main function of primary packaging is to restrict climatic, chemical, or biological hazards that cause deterioration. The rising need for the aseptic filling and the sealing of drug molecules into sterile containers and the increasing demand for parenteral vials and prefillable syringes are supporting the growth of this segment.

The liquid packaging equipment segment is expected to account for the largest share of the pharmaceutical packaging equipment market

The liquid packaging equipment segment accounted for the largest share of the pharmaceutical packaging equipment market. The large share of the liquid packaging equipment segment is mainly attributed to the high production of liquid formulations and the increasing incidence of eye and ear disorders across the globe.

Europe to dominate the pharmaceutical packaging equipment market during the forecast period

The pharmaceutical packaging equipment market in Europe dominated the pharmaceutical packaging equipment market in the forecast period.

Growth in the European market is majorly driven by the high pharmaceutical production, increasing demand for flexible packaging equipment by major pharmaceutical manufacturers, and the rising focus on product diversification by companies, which is driving the demand for innovative packaging equipment. Regulatory changes are also compelling pharmaceutical manufacturers to replace their older equipment with new equipment to adhere to the changing standards.

Rising Need for Flexible and Integrated Packaging Equipment to Drive Market Growth

Primary Packaging Equipment Segment to Account for the Largest Share of APAC Market in 2021

China to Register the Highest Growth During Forecast Period

Europe to Dominate Pharmaceutical Packaging Equipment Market

Developing Markets to Register Higher Growth During Forecast Period

High Growth in Generics & Biopharmaceuticals Markets

Growing Need for Flexible and Integrated Packaging Equipment

Increase in Offshore Pharmaceutical Manufacturing

Growing Contract Manufacturing of Pharmaceutical Products

Introduction of Regulatory Standards on Packaging and Stringent Norms Against Counterfeit Products

Innovation in Pharmaceutical Packaging and Delivery System

Growth in OTC Drug Sales and Regulations to Reduce OTC Counterfeit

Growing Preference for Refurbished Equipment

Growth of Pharmaceutical Manufacturing in Emerging Economies

Rising Demand for Automated Packaging

Change in Medication Systems to Self-Medication and Self-Care

Increasing Pharmaceutical R&D Investments

Growth in Personalized and Precision Medicine Supply Chain

Uncertainties in Regulations and Standards of Pharmaceutical Packaging Process

Development of Production Lines for Small Batch Sizes and Research Purposes

Automation and Integration of Packaging Equipment

Growing Focus on Labeling and Serialization for Anti-Counterfeiting of Drugs

Growing Demand for Aseptic Filling and Sealing Equipment

Case Study: Qualitative Insight Based on Speed of the Machine

Accutek Pharmaceutical Equipment Companies, Inc

Bausch+Strobel Maschinenfabrik Ilshofen GmbH + Co. Kg

Industria Macchine Automatiche S.P.A. (Ima S.P.A)

Marchesini Group S.P.A.

Robert Bosch GmbH (Syntegon Technology GmbH)

Trustar Pharma Pack Equipment Co., Ltd

For more information about this report visit https://www.researchandmarkets.com/r/ri8y54

View source version on businesswire.com: https://www.businesswire.com/news/home/20220421005657/en/

ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Fight back against inflation. This is how Dalio does it.

(Bloomberg) -- Bill Gates has a short position against Tesla Inc. that would now need between $1.5 billion and $2 billion to close out, Elon Musk said Friday in a series of tweets.Most Read from BloombergElon Musk Says Bill Gates Has ‘Multi-Billion Dollar’ Tesla Short PositionRussian Wins in Eastern Ukraine Spark Debate Over Course of WarFord Beats Tesla to the Punch With First Electric F-150 DeliveryBitcoin Breaks From Stocks and Keeps On Falling as Crypto SlidesZilingo’s Fired CEO Responds to

Stop investing in mediocre businesses. Buy the best, instead.

‘I have made an earnest attempt to get the bank to take their money back, so I was wondering if at any point or time the money would become legally mine.’

Whether you're looking for household goods at discounted prices or need to buy your grocery items in bulk, Costco is the go-to retailer for millions of shoppers across the U.S. But despite its ability to attract a loyal following, Costco has made a number of changes recently that haven't thrilled customers. In April, the warehouse retailer got rid of its special COVID hours for seniors, and just this month, Costco ended its mortgage program for members. Now, the retailer has a new warning for sh

Will we have enough to ‘live a simple life’ in retirement? Many other retirees wonder the same thing as you, and may be in similar financial circumstances where they’re able to pay the bills and have money saved in their retirement accounts. Your interest rate is fantastic, you’re capable of making the monthly payment from just your pension and Social Security without tapping into your 401(k) and you have so much of your home already paid off — all wins.

The stock market pulled back from the brink of a bear market as rate-hike expectations eased, at least for now. Here's what it will take to signal a bottom.

Lady Gaga just shared a new selfie to Instagram and she's gone topless / no-makeup for the pic, sharing a glimpse of her natural skin texture without filters

Markets are shaky. Your income stream doesn’t have to be.

Giving too much money to these giants? Then start collecting rent from them.

Despite all the attention that renewable energy companies get, having operations in the renewable energy space alone does not make a stock a buy. In fact, several renewable energy companies are struggling just to stay profitable. Let's discuss two renewable energy stocks that look attractive right now, and one that's best avoided.

What happened Shares of drugmaker Novavax (NASDAQ: NVAX) are up to the tune of 18.9% as of 2:11 p.m. ET Friday, according to data from S&P Global Market Intelligence, thanks to a confluence of events that work in the company's favor.

When looking for the best artificial intelligence stocks to buy, identify companies using AI technology to improve products or gain a strategic edge, such as Google, Microsoft and Nvidia.

Many Americans are surprised to see they have not prepared as well as they had hoped for retirement when they finally get ready to call it quits. The bad news is, you’ll probably have to make some realistic assumptions of what your retirement will look like. If you’ve lived primarily paycheck to paycheck in your working years, that may continue to feel the case in your retirement.

In this article, we discuss the 10 stocks that Jim Cramer and hedge funds agree on. If you want to read about some more stocks that Jim Cramer and hedge funds agree on, go directly to Jim Cramer and Hedge Funds Agree on These 5 Stocks. In the past few weeks, Jim Cramer, the journalist […]

Financial technology company Upstart Holdings (NASDAQ: UPST) has proven to be one of the most volatile stocks on Wall Street since going public at the end of 2020. Investors were shocked when Upstart's 2022 first-quarter earnings report revealed a surge in loans on the company's balance sheet, a potentially risky situation in an economy that appears to be slowing. Upstart receives a fee for the loans it touches, making it more a technology platform than an actual lender.

Here's what a fundamental and technical analysis says about Google stock. GOOGL stock buybacks remain high as web search and YouTube advertising rebound. But cloud computing growth is key.

Stocks have been inching back in recent days from the brink of bear market territory. It may be time to scoop up shares at steep discounts.

Five billionaires lost a total of $300 billion recently as their fortunes plummeted during the recent market downturn, according to the Bloomberg Billionaires Index, which is a daily ranking of the world's richest people. The billionaires who lost the most amount of net worth include the world's three richest men, Elon Musk, Jeff Bezos and Bernard Arnault, who is the CEO of luxury goods retailer LVMH Moët Hennessy . Meta Platforms CEO Mark Zuckerberg and Changpeng Zhao, CEO of Binance, a cryptocurrency exchange, saw their fortunes decline by $135 billion.

Real estate mogul Barbara Corcoran didn't mince words when asked about Tesla (TSLA) CEO Elon Musk's recent behavior.